Thursday, December 23, 2021: Life Sciences

The FDA authorized Pfizer Inc.’s Paxlovid for high-risk patients 12 and older, making it the first antiviral pill to treat COVID-19 in the United States. Even so, it will likely be months before the pills are widely available. Jeff Zients, coordinator of the...

Thursday, December 23, 2021: D.C. News

The Supreme Court said it will fast-track a review of the Biden administration’s COVID-19 vaccination rules for private employers and health care workers, with oral arguments set for January 7. The mandates are still working their way through the lower courts,...

Tuesday, December 21, 2021: Mental Health

The U.S. Department of Health and Human Services (HHS) announced $282 million in additional funding to transition a nationwide suicide prevention hotline from its 10-digit number to three digits: 988. The funding includes more money to help states staff up existing...